Skip to main content
. 2022 Nov 3;9:1025919. doi: 10.3389/fnut.2022.1025919

TABLE 1.

The characteristics of studies.

Study, year N Design TRE Window Methods of tracking TRE Type of patients
Arnason and Kerry (19) 10 Three-phase observational study (2-week baseline, 2-week intervention, 2-week follow up) 4–6 h eating window; 2 weeks Self-reporting; remote food photography for a random 3-day food diary T2DM (fasting glucose > 7.0 mmol, HbA1c > 6.5%, or OGTT > 11.0 mmol)
Andriessen et al. (12) 14 Randomized crossover trial within a 10 h window no later than 18:00 h
10 weeks
A weekly phone call T2DM, BMI > 25 kg/m
Chair et al. (15) 101 RCT (randomized into the ADF group, 18/8 TRF group, and control group) 8-h TRE; 3 weeks Individualized menus and counseling; weekly telephone calls from nurse Prediabetes
Che et al. (11) 120 RCT (TRE and control group) 10-h TRE (8 a.m.–6 p.m.); 12 weeks A daily log was used to record T2DM
Kahleova et al. (16) 54 RCT (randomized, open, crossover, single-center study) breakfast (6–10 a.m.); lunch (12:00–4 p.m.)
12 weeks
All the meals were provided for one half of the participants; dietary record T2DM
Parr et al. (17) 19 The non-randomized study 9 h TRE (10 a.m.–7 p.m.), 4 weeks Written food diary or smartphone app to record all food entries. Photos of each food/beverage also taken using phone T2DM (HbA1c > 6.5 and < 9%) and eating window > 12 h
Sutton et al. (18) 8 Randomized crossover trial 6 h TRE (no later than 14;00 h), 5 weeks All meals provided and consumed under supervision Prediabetes

TRE, Time-restricted eating; TRF, Time-restricted feeding; BMI, Body Mass Index; ADF, Alternate-day Fasting; T2DM, Diabetes Mellitus type 2; HbA1c, Glycosylated Hemoglobin, Type A1c; OGTT, Oral Glucose Tolerance Test; RCT, Randomized Clinical Trial.